Under construction – not a live service
Sign in
Taking people in United StatesNo phase

ECMO ABI Detection With Hyperfine

Key facts

Where
Kansas City, United StatesSee the site

Where in United States

  • Children's MercyKansas City, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Children's Mercy Hospital Kansas City
Trial code
NCT06469801
Record updated
24 September 2026
Original description
The primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.Read full original descriptionShow less

Low-Field Bedside MRI for Detection of Acute Brain Injury in Pediatric Extracorporeal Membrane Oxygenation

The primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.

Inclusion: Participants that will be or are admitted to the Pediatric Intensive Care Unit, Cardiac Intensive Care Unit, or the Neonatal Intensive Care Unit; Ages 0-17 years; Participants that are at high risk for undergoing ECMO or are currently undergoing venovenous or venoarterial ECMO; High risk participants include, but are not limited to:; Undergoing cardiac surgery; Congenital heart disease; Congenital diaphragmatic hernia; Refractory hypoxemic and/or hypercarbic respiratory failure; Vasoactive-refractory shock.

Exclusion: Patients with a passive or active implant will:; First be reviewed on MRISafety.com to determine MR conditionality; If device is listed as Conditional or Unsafe for a 1.5T or a 3T, device will then be reviewed by MRI Safety Officer or MRI Physician Section chief to determine true conditionality for the portable MRI; Pregnancy; Any patient who has a contraindication to having an MRI.

ClinicalTrials.gov NCT06469801